Burrill, Sciona, and Genaissance

From a business wire:

Burrill & Company announced today their investment in Sciona, Inc. Sciona is the leading company in the field of consumer-oriented genetic diagnostics. Based on the latest scientific research, Sciona has created a genetic diagnostic panel that enables manufacturers to customize personal care and nutrition products based on a person’s genetic makeup. Sciona is currently located in Cambridge, UK, but plans to relocate to New Haven, Connecticut, to be nearer to strategic partner and equity stakeholder, Genaissance, Inc.

No comment yet. Just watching.


Comments are closed.